Novavax, Inc.
NVAX
$8.85
$0.374.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.41% | 451.51% | 54.58% | 7.25% | 179.93% |
| Total Depreciation and Amortization | -32.06% | -31.34% | 15.96% | 12.18% | 10.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -104.71% | 54.19% | -238.60% | -54.91% | -49.55% |
| Change in Net Operating Assets | -308.57% | -2,258.47% | 1.91% | -219.07% | 139.65% |
| Cash from Operations | -140.56% | -122.01% | 2.05% | -265.18% | 282.78% |
| Capital Expenditure | 91.41% | 82.26% | 78.14% | 92.44% | 58.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 130.11% | -19,281.45% | -19,441.42% | 14,384.98% | -45,784.86% |
| Cash from Investing | 129.81% | -911.30% | 1,686.33% | 273.52% | -4,691.19% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -67.21% | -511.39% | -18.84% | -129.12% | 19.21% |
| Issuance of Common Stock | -- | -- | -- | -99.79% | 317.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 688.96% | -688.96% | -- | -- | -- |
| Cash from Financing | -100.40% | -219.96% | -103.41% | -100.05% | 320.99% |
| Foreign Exchange rate Adjustments | 5,167.95% | 68.53% | -467.40% | -35.51% | 74.84% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -104.76% | -203.63% | 47.55% | -172.07% | 267.75% |